- Country: Brazil
- Summary: Pilocarpine 2% Colirio Fr 10 Ml, Sodic Blue Sol Patent Va 2.5% - 2 Ml, Bright Blue 0.05% (0.5Mg/Ml)
- BRT Ref No: 125927638
- Deadline: 18 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 91186/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Pilocarpine 2% Colirio FR 10 ml, Sodico Blue Save Patent Va 2.5% - 2 ml, bright blue 0.05% (0.5mg/ml) f/A 1ml (manipulated) and PVPI 5% colirio fr 5ml
UASG Code: 532101
Notice from: 08/09/2025 from 08:00 to 17:59 hs
Proposal delivery: fromccb25dd379407458d1bf3bd9c3c3eda6 of 08/09/2025 at 08:00
Pharmaceutical
Intraocular
: 72
Additional characteristics specially manipulated medicine
: 756 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPilocarpine 2% Colirio Fr 10 Ml, Sodic Blue Sol Patent Va 2.5% - 2 Ml, Bright Blue 0.05% (0.5Mg/Ml) - Brazil Tender
The SAO PAULO STATE GOVERNMENT, a Government sector organization in Brazil, has announced a new tender for Pilocarpine 2% Colirio Fr 10 Ml, Sodic Blue Sol Patent Va 2.5% - 2 Ml, Bright Blue 0.05% (0.5Mg/Ml). This tender is published on BrazilTenders under BRT Ref No: 125927638 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-18.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
